Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L31 pseudogene 13 (RPL31P13)
- Target
- RPL31P13
- Molecular classification
- Other (pseudogene)
01
Overview
Ribosomal protein L31 pseudogene 13 (RPL31P13) is a human pseudogene annotated in databases such as NCBI Gene (100270983) and Ensembl (ENSG00000228646)[2][11]. Pseudogenes like RPL31P13 are genomic sequences similar to known genes (in this case, ribosomal protein L31, which is a constituent of the ribosome), but typically lack the ability to encode a functional protein due to disabling mutations and/or incomplete gene sequences. The canonical, functional ribosomal protein L31 is a component of the 60S ribosomal subunit, an essential part of cellular protein synthesis machinery[3], but RPL31P13 does not produce this protein. Therefore, RPL31P13 is not a druggable target and does not participate in protein synthesis or other defined biological pathways relevant to therapeutic targeting[2][11].
- Other names
- RPL31_2_164RPL31P13
02
Mechanism of action
None (no mechanism of action; no protein product)
03
Biological functions
Other (no known biological function; pseudogenes do not produce functional protein)
04
Disease associations
Other (no established disease association for the pseudogene itself; functional RPL31 [not RPL31P13] is associated with certain anemias[3], but RPL31P13 does not have such associations[2][11])
05
Safety considerations
None specific; pseudogenes do not convey direct safety concerns in a therapeutic context[2][11]
06
Biomarkers
None specific; pseudogenes rarely serve as biomarkers, though expression analysis may occasionally be included in broad panels for research[5][6]
Beyond the preview
Go deeper on Ribosomal protein L31 pseudogene 13 (RPL31P13).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L31 pseudogene 13 (RPL31P13).